Filing Flows › Addus HomeCare (ADUS) › Guidance & outlook
Addus HomeCare (ADUS) guidance and outlook
Addus HomeCare's 10-Q filed Nov 4, 2026 makes 5 forward-looking statements.
Guidance and outlook
Forward-looking statements, 10-Q filed Nov 4, 2026
- On September 12, 2026, the Company entered into a definitive equity and asset purchase agreement to acquire the personal care division of AccentCare, Inc. for an anticipated purchase price, after customary purchase price adjustments, of approximately $275.0 million.
- The Company expects to close the AccentCare Acquisition following completion of regulatory approvals and subject to customary closing conditions and to fund it through a combination of the Company’s revolver and cash on hand.
- Our business will benefit from the rate increases noted above for 2026, but there is no assurance that there will be additional rate increases in Illinois in future fiscal years to offset increases in minimum wage, and our financial performance will be adversely impacted for any periods in which an additional offsetting reimbursement rate increase is not in effect.
- Although we believe our liquidity position remains strong, we can provide no assurance that we will remain in compliance with the covenants in our Credit Agreement, and in the future, it may prove necessary to seek an amendment with the bank lending group under our credit facility.
- Additionally, there can be no assurance that we will be able to raise additional funds on terms acceptable to us, if at all.
Addus HomeCare's latest quarter
Addus HomeCare, Q3 2026: revenue $388M (+7% year over year), operating margin 10.3%, net earnings $28.6M, operating cash flow $40.9M. The chart follows the revenue to costs, profit and cash.
Questions
What does Addus HomeCare expect?
On September 12, 2026, the Company entered into a definitive equity and asset purchase agreement to acquire the personal care division of AccentCare, Inc. for an anticipated purchase price, after customary purchase price adjustments, of approximately $275.0 million. The Company expects to close the AccentCare Acquisition following completion of regulatory approvals and subject to customary closing conditions and to fund it through a combination of the Company’s revolver and cash on hand. Our business will benefit from the rate increases noted above for 2026, but there is no assurance that ther
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.